Findings seen for both all-cause and cardiovascular disease mortality
THURSDAY, March 20, 2025 (HealthDay News) — Adults with arthritis and chronic obstructive pulmonary disease (COPD) have a higher risk for mortality than individuals without COPD, according to a study recently published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.
Yingying Zhang, from the Affiliated Wuxi Fifth Hospital of Jiangnan University in China, and colleagues used data from 11,298 participants in the National Health and Nutrition Examination Survey (1999 to 2018) to evaluate the correlation between COPD and mortality among participants with arthritis.
The researchers found that during 8.8 years of follow-up, COPD was significantly associated with both all-cause and cardiovascular disease (CVD) mortality among participants with arthritis (hazard ratio [HR] for all-cause mortality with arthritis and COPD, 1.41; 95 percent confidence interval [CI], 1.25 to 1.60; and HR for CVD mortality, 1.29; 95 percent CI, 1.08 to 1.53). Higher rates of both all-cause and CVD mortality were observed among participants with COPD with Kaplan-Meier survival curves. Additionally, with COPD, there was an increased risk for both chronic lower respiratory disease (CLRD) mortality (HR, 5.46; 95 percent CI, 3.48 to 8.56) and non-CLRD mortality (HR, 1.24; 95 percent CI, 1.07 to 1.44).
“These results not only offer valuable insights into the intricate relationship between COPD and arthritis but also imply that clinicians should adopt a more holistic approach to managing these patients, prioritizing the identification and management of comorbidities that may exacerbate clinical outcomes,” the authors write.
Cognitive, Manual Impairment Tied to Unacceptable Inhaler Technique
Significant Changes in Voice Noted
During Exacerbation of Asthma, COPD
Financial Toxicity Is a Significant Issue for Patients With COPD
Gaps Exist in Clinician Communications About Wildfire Smoke Risk
Study IDs Dementia Risk Factors in Those Older Than 90 Years
Obesity Has Increased Significantly in U.S. Adults and Youths Since 1999
Benzodiazepine Use Has Plateaued in Older Adults
About One-Third of Men Continuously Using Tamsulosin See Minimal to No Effect